業績 2013-2014年

  1. Tsuruta Y, Mochizuki T, Moriyama T, Itabashi M, Takei T, Tsuchiya K, Nitta K.: Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol. 2014 Jul 22. [Epub ahead of print]
  2. Ando K, Nitta K, Rakugi H, Nishizawa Y, Yokoyama H, Nakanishi T, Kashihara N, Tomita K, Nangaku M, Takahashi K, Isshiki M, Shimosawa T, Fujita T:Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) study. Int J Med Sci. 2014 Jun 21;11(9):897-904. doi: 10.7150/ijms.9026. eCollection 2014.
  3. Manabe S, Oshima Y, Nakano M, Fujii T, Maehara T, Nitta K, Hatano M: Renal infarction in a patient with pulmonary vein thrombosis after left upper lobectomy. Case Rep Nephrol Urol. 2014 May 22;4(2):103-8. doi: 10.1159/000363224. eCollection 2014 May.
  4. Nagai T, Nitta K, Kanasaki M, Koya D, Kanasaki K: The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis. Clin Exp Nephrol. 2014 Jul 1. [Epub ahead of print]
  5. Tsuruta Y, Nitta K, Akizawa T, Fukuhara S, Saito A, Karaboyas A, Li Y, Port FK, Robinson BM, Pisoni RL, Akiba T: Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS. Int Urol Nephrol. 2014 Jun 8. [Epub ahead of print]
  6. Hara M, Ando M, Maeda Y, Tsuchiya K, Nitta K.: Proteinuria is a simple sign of systemic inflammation that leads to a poor prognosis in individuals affected with non-Hodgkin lymphoma. Clin Nephrol. 2014 Jul;82(1):51-7. doi: 10.5414/CN108132.
  7. Kanasaki K, Nagai T, Nitta K, Kitada M, Koya D: N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes. Front Pharmacol. 2014 Apr 14;5:70. doi: 10.3389/fphar.2014.00070. eCollection 2014. Review.
  8. Shiohira S, Yoshida T, Sugiura H, Nishida M, Nitta K, Tsuchiya K: Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis. Physiol Rep. 2013 Dec 5;1(7):e00172. doi: 10.1002/phy2.172. eCollection 2013 Dec 1.
  9. Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A: Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study. Clin Exp Nephrol. 2014 Mar 30. [Epub ahead of print]
  10. Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K: Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014 Mar 21;9(3):e91756. doi: 10.1371/journal.pone.0091756. eCollection 2014.
  11. Nitta K, Okada K, Yanai M, Takahashi S: Aging and chronic kidney disease. Kidney Blood Press Res. 2013;38(1):109-20. doi: 10.1159/000355760. Epub 2014 Mar 3.
  12. Ishiguro N, Uruga T, Sekizawa O, Tsuji T, Suzuki M, Kawamura N, Mizumaki M, Nitta K, Yokoyama T, Tada M: Visualization of the heterogeneity of cerium oxidation states in single Pt/Ce?Zr?O(x) catalyst particles by nano-XAFS. Chemphyschem. 2014 Jun 6;15(8):1563-8. doi: 10.1002/cphc.201400090. Epub 2014 Mar 11.
  13. Okazaki M, Komatsu M, Kawaguchi H, Tsuchiya K, Nitta K: Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients. Blood Purif. 2014;37(2):106-12. doi: 10.1159/000358215. Epub 2014 Mar 5.
  14. Kawanishi K, Sawada A, Ochi A, Moriyama T, Mitobe M, Mochizuki T, Honda K, Oda H, Nishikawa T, Nitta K: Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature. Case Rep Nephrol Urol. 201
  15. Itabashi M, Takei T, Moriyama T, Shiohira S, Shimizu A, Tsuruta Y, Uchida K, Nitta K: Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index. Mod Rheumatol. 2014 Jan;24(1):112-9. doi:
  16. Shimizu A, Takei T, Moriyama T, Itabashi M, Uchida K, Nitta K.Clinical and pathological studies of IgA nephropathy presenting as a rapidly progressive form of glomerulonephritis. Intern Med. 2013;52(22):2489-94.
  17. Koike M, Nitta K.[Treatment of hypertriglyceridemia: plasma exchange].Nihon Rinsho. 2013 Sep;71(9):1667-9. Review. Japanese.
  18. Otani Y, Otsubo S, Kimata N, Takano M, Abe T, Okajima T, Miwa N, Tsuchiya K, Nitta K, Akiba T.Effects of the ankle-brachial blood pressure index and skin perfusion pressure on mortality in hemodialysis patients.Intern Med. 2013;52(21):2417-21.
  19. Kimata N, Wakayama K, Okano K, Hibi A, Sawada A, Tajima Y, Makabe S, Tsuchiya K, Mineshima M, Nitta K, Akiba T.Study of discrepancies between recorded and actual blood flow in hemodialysis patients. ASAIO J. 2013 Nov-Dec;59(6):617-21. doi: 10.1097/MAT.0b013e3182a708b9.
  20. Yanagisawa N, Muramatsu T, Yamamoto Y, Tsuchiya K, Nitta K, Ajisawa A, Fukutake K, Ando M.Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate. Clin Exp Nephrol. 2014 Aug;18(4):600-5. doi: 10.1007/s10157-013-0853-1. Epub 2013 Aug 17.
  21. Miyaoka T, Mochizuki T, Takei T, Tsuchiya K, Nitta K. Serum uric acid levels and long-term outcomes in chronic kidney disease. Heart Vessels. 2014 Jul;29(4):504-12. doi: 10.1007/s00380-013-0396-0. Epub 2013 Aug 9.
  22. Hara M, Ando M, Morito T, Nokiba H, Iwasa Y, Tsuchiya K, Nitta K.S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease. Nephron Clin Pract. 2013;123(3-4):202-8. doi: 10.1159/000353808. Epub 2013 Aug 6.
  23. Ogawa T, Shimizu H, Kyono A, Sato M, Yamashita T, Otsuka K, Nitta K. Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study. Int Urol Nephrol. 2014 Jan;46(1):151-9. doi: 10.1007/s11255-013-0494-z. Epub 2013 Jun 27.
  24. Kamei D, Moriyama T, Takei T, Wakai S, Nitta K.Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. Clin Exp Nephrol. 2014 Apr;18(2):320-8. doi: 10.1007/s10157-013-0822-8. Epub 2013 Jun 7.
  25. Yamashita T, Ogawa T, Takahashi M, Mitsuhashi T, Shizuku J, Takahashi N, Ohba T, Miyajima S, Kabaya T, Otsuka K, Nitta K. Additional reduction in serum phosphorus levels by pulverized lanthanum carbonate chewable in hemodialysis patients. Ther Apher Dial. 2013 Apr;17 Suppl 1:54-9. doi: 10.1111/1744-9987.12036
  26. Yajima A, Inaba M, Tominaga Y, Tanaka M, Otsubo S, Nitta K, Ito A, Satoh S.Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease. Ther Apher Dial. 2013 Apr;17 Suppl 1:41-8. doi: 10.1111/1744-9987.12038.
  27. Sato K, Ishida H, Uchida K, Nitta K, Tanabe K.Risk factors for recurrence of immunoglobulin a nephropathy after renal transplantation: single center study. Ther Apher Dial. 2013 Apr;17(2):213-20. doi: 10.1111/j.1744-9987.2012.01139.x. Epub 2012 Dec 11.
  28. Muramatsu T, Yanagisawa N, Chikasawa Y, Seita I, Yotsumoto M, Otaki M, Ogata K, Hagiwara T, Suzuki T, Suganuma A, Imamura A, Amano K, Yamamoto Y, Nitta K, Ajisawa A, Fukutake K, Ando M. [Prevalence of chronic kidney disease among HIV-infected individuals in Japan--a report from two tertiary hospitals]. Kansenshogaku Zasshi. 2013 Jan;87(1):14-21. Japanese.
  29. Hanaoka M, Gono T, Kawaguchi Y, Uchida K, Koseki Y, Katsumata Y, Kaneko H, Takagi K, Ichida H, Nitta K, Yamanaka H.Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. Rheumatology (Oxford). 2013 Dec;52(12):2149-57. doi: 10.1093/rheumatology/ket108. Epub 2013 Mar 5.
  30. Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A Clinical correlates of ambulatory BP monitoring among patients with CKD.; Chronic Kidney Disease Japan Cohort Study Group. Clin J Am Soc Nephrol. 2013 May;8(5):721-30. doi: 10.2215/CJN.06470612. Epub 2013 Feb 14.]
  31. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry; Japanese Society of Nephrology. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol. 2013 Apr;17(2):155-73. doi: 10.1007/s10157-012-0746-8. Epub 2013 Feb 6.
  32. Tsuchiya K, Nitta K.Hepcidin is a potential regulator of iron status in chronic kidney disease. Ther Apher Dial. 2013 Feb;17(1):1-8. doi: 10.1111/1744-9987.12001. Epub 2012 Dec 16. Review.
  33. Hara M, Nemoto T, Hijima T, Tsuchiya K, Nitta K, Ando M. A case of IgA nephropathy associated with mycosis fungoides that developed into rapidly progressive glomerulonephritis. Clin Nephrol. 2013 Feb;79(2):161-5.
  34. Sugimoto H, Ogawa T, Iwabuchi Y, Otsuka K, Nitta K Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients. .Int Urol Nephrol. 2014 Jan;46(1):99-106. doi: 10.1007/s11255-013-0386-2. Epub 2013 Jan 25.
  35. Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol. 2013 Oct;17(5):730-42. doi: 10.1007/s10157-012-0758-4. Epub 2013 Jan 16.
  36. Moriyama T, Iwasaki C, Tanaka K, Ochi A, Shimizu A, Shiohira S, Itabashi M, Takei T, Uchida K, Tsuchiya K, Nitta K. Effects of combination therapy with renin-angiotensin system inhibitors and eicosapentaenoic acid on IgA nephropathy. Intern Med. 2013;52(2):193-9. Epub 2013 Jan 15.
  37. Yanagisawa N, Ando M, Tsuchiya K, Nitta K.Impact of cystatin C elevation and albuminuria on probability of adverse outcomes in HIV-infected men receiving HAART. Clin Nephrol. 2013 May;79(5):362-9. doi: 10.5414/CN107668.
  38. Taneda S, Honda K, Aoki A, Nitta K, Tamura T, Yoshioka Y, Oda H.An autopsy case of clinically un-diagnosed autosomal recessive polycystic kidney disease in 77-year-old male.Pathol Int. 2012 Dec;62(12):811-6. doi: 10.1111/pin.12011.
  39. Takei T, Itabashi M, Moriyama T, Kojima C, Shiohira S, Shimizu A, Tsuruta Y, Ochi A, Amemiya N, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrol Dial Transplant. 2013 May;28(5):1225-32. doi: 10.1093/ndt/gfs515. Epub 2012 Dec 13.
  40. Yamagata K, Usui J, Sugiyama H, Nitta K, Wada T, Muso E, Arimura Y, Koyama A, Makino H, Matsuo S.Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey. Clin Exp Nephrol. 2013 Oct;17(5):646-9. doi: 10.1007/s10157-012-0740-1. Epub 2012 Dec 14. Review. Erratum in: Clin Exp Nephrol. 2013 Oct;17(5):650-1.